135 related articles for article (PubMed ID: 11062244)
1. An activation switch in the ligand binding pocket of the C5a receptor.
Gerber BO; Meng EC; Dotsch V; Baranski TJ; Bourne HR
J Biol Chem; 2001 Feb; 276(5):3394-400. PubMed ID: 11062244
[TBL] [Abstract][Full Text] [Related]
2. Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site.
Higginbottom A; Cain SA; Woodruff TM; Proctor LM; Madala PK; Tyndall JD; Taylor SM; Fairlie DP; Monk PN
J Biol Chem; 2005 May; 280(18):17831-40. PubMed ID: 15661745
[TBL] [Abstract][Full Text] [Related]
3. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
[TBL] [Abstract][Full Text] [Related]
4. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN
Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387
[TBL] [Abstract][Full Text] [Related]
5. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.
Christophe T; Rabiet MJ; Tardif M; Milcent MD; Boulay F
J Biol Chem; 2000 Jan; 275(3):1656-64. PubMed ID: 10636859
[TBL] [Abstract][Full Text] [Related]
6. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
7. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
[TBL] [Abstract][Full Text] [Related]
8. C5a receptor activation. Genetic identification of critical residues in four transmembrane helices.
Baranski TJ; Herzmark P; Lichtarge O; Gerber BO; Trueheart J; Meng EC; Iiri T; Sheikh SP; Bourne HR
J Biol Chem; 1999 May; 274(22):15757-65. PubMed ID: 10336477
[TBL] [Abstract][Full Text] [Related]
9. Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs.
DeMartino JA; Konteatis ZD; Siciliano SJ; Van Riper G; Underwood DJ; Fischer PA; Springer MS
J Biol Chem; 1995 Jul; 270(27):15966-9. PubMed ID: 7608153
[TBL] [Abstract][Full Text] [Related]
10. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
[TBL] [Abstract][Full Text] [Related]
11. Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor.
Cain SA; Coughlan T; Monk PN
Biochemistry; 2001 Nov; 40(46):14047-52. PubMed ID: 11705397
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation and endocytosis of the complement factor 5a receptor: evidence for multiple activated conformations of a G protein-coupled receptor.
Whistler JL; Gerber BO; Meng EC; Baranski TJ; von Zastrow M; Bourne HR
Traffic; 2002 Dec; 3(12):866-77. PubMed ID: 12453150
[TBL] [Abstract][Full Text] [Related]
13. C5aR ligand peptide 3D QSAR study performed with an applied linear conformation.
Anderson CY; Kellogg GE; Freer RJ
J Pept Res; 1997 Jun; 49(6):476-83. PubMed ID: 9266474
[TBL] [Abstract][Full Text] [Related]
14. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway.
Braun L; Christophe T; Boulay F
J Biol Chem; 2003 Feb; 278(6):4277-85. PubMed ID: 12464600
[TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of the guinea pig C5a anaphylatoxin receptor: interspecies diversity among the C5a receptors.
Fukuoka Y; Ember JA; Yasui A; Hugli TE
Int Immunol; 1998 Mar; 10(3):275-83. PubMed ID: 9576615
[TBL] [Abstract][Full Text] [Related]
17. Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function.
Geva A; Lassere TB; Lichtarge O; Pollitt SK; Baranski TJ
J Biol Chem; 2000 Nov; 275(45):35393-401. PubMed ID: 10952985
[TBL] [Abstract][Full Text] [Related]
18. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
Hagemann IS; Narzinski KD; Floyd DH; Baranski TJ
J Biol Chem; 2006 Dec; 281(48):36783-92. PubMed ID: 17023413
[TBL] [Abstract][Full Text] [Related]
19. Identification of the major phosphorylation sites in human C5a anaphylatoxin receptor in vivo.
Giannini E; Brouchon L; Boulay F
J Biol Chem; 1995 Aug; 270(32):19166-72. PubMed ID: 7642584
[TBL] [Abstract][Full Text] [Related]
20. The influence of Lys68 in decepeptide agonists of C5a on C5a receptor binding, activation and selectivity.
Vogen SM; Finch AM; Wadi SK; Thatcher J; Monk PN; Taylor SM; Sanderson SD
J Pept Res; 1999 Jan; 53(1):8-17. PubMed ID: 10195437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
